Your browser doesn't support javascript.
loading
ID2 inhibits lung adenocarcinoma cell malignant behaviors by inhibiting the activation of the PI3K/AKT/mTOR signaling pathway.
Peng, Wenzhong; Chen, Jia; He, Ruoxi; Tang, Yongjun; Jiang, Juan; Li, Ying.
Affiliation
  • Peng W; Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital, Central South University, Changsha 410078, China.
  • Chen J; The Second Department of Respiratory Medicine, Third People's Hospital of Pingxiang City, Pingxiang 337000, China.
  • He R; Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital, Central South University, Changsha 410078, China.
  • Tang Y; Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital, Central South University, Changsha 410078, China.
  • Jiang J; Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital, Central South University, Changsha 410078, China.
  • Li Y; Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital, Central South University, Changsha 410078, China. Electronic address: Liying971@163.com.
Tissue Cell ; 79: 101950, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36274350
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Tissue Cell Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Tissue Cell Year: 2022 Document type: Article Affiliation country: China